Artículos de revistas sobre el tema "Drug repurposing in anti-candida therapy"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Drug repurposing in anti-candida therapy".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Hijazi, Mohamad Ali, André Gessner y Nahed El-Najjar. "Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp". Cancers 15, n.º 12 (15 de junio de 2023): 3199. http://dx.doi.org/10.3390/cancers15123199.
Texto completoWahedi, Hussain Mustatab y Deeba Amraiz. "Repurposing of Antiviral Drugs for Covid-19 Therapy". Life and Science 1, supplement (23 de diciembre de 2020): 10. http://dx.doi.org/10.37185/lns.1.1.151.
Texto completoWu, King-Chuen, Kai-Sheng Liao, Li-Ren Yeh y Yang-Kao Wang. "Drug Repurposing: The Mechanisms and Signaling Pathways of Anti-Cancer Effects of Anesthetics". Biomedicines 10, n.º 7 (4 de julio de 2022): 1589. http://dx.doi.org/10.3390/biomedicines10071589.
Texto completoRamachandran, Sharavan y Sanjay K. Srivastava. "Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy". Molecular Therapy - Oncolytics 19 (diciembre de 2020): 19–32. http://dx.doi.org/10.1016/j.omto.2020.08.019.
Texto completoKhan, Raheel, Harras Khan, Yassen Abdullah y Q. Ping Dou. "Feasibility of Repurposing Clioquinol for Cancer Therapy". Recent Patents on Anti-Cancer Drug Discovery 15, n.º 1 (13 de mayo de 2020): 14–31. http://dx.doi.org/10.2174/1574892815666200227090259.
Texto completoAjetunmobi, Olabayo H., Gina Wall, Bruna Vidal Bonifacio, Lucero A. Martinez Delgado, Ashok K. Chaturvedi, Laura K. Najvar, Floyd L. Wormley et al. "High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms". Journal of Fungi 9, n.º 9 (27 de agosto de 2023): 879. http://dx.doi.org/10.3390/jof9090879.
Texto completoVatter, Tatjana, Lukas Klumpp, Katrin Ganser, Nicolai Stransky, Daniel Zips, Franziska Eckert y Stephan M. Huber. "Against Repurposing Methadone for Glioblastoma Therapy". Biomolecules 10, n.º 6 (17 de junio de 2020): 917. http://dx.doi.org/10.3390/biom10060917.
Texto completoPeyclit, Lucie, Hanane Yousfi, Jean-Marc Rolain y Fadi Bittar. "Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi". Pharmaceuticals 14, n.º 5 (20 de mayo de 2021): 488. http://dx.doi.org/10.3390/ph14050488.
Texto completoDoumat, George, Darine Daher, Morgan Bou Zerdan, Nasri Nasra, Hisham F. Bahmad, Monica Recine y Robert Poppiti. "Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems". Current Oncology 30, n.º 1 (5 de enero de 2023): 704–19. http://dx.doi.org/10.3390/curroncol30010055.
Texto completoRivas, Sarah, Vaidya Govindarajan, Mynor Mendez Valdez, John Heiss y Ashish Shah. "EXTH-34. ANTI-RETROVIRAL REPURPOSING FOR TREATMENT OF GLIOBLASTOMA". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii216—vii217. http://dx.doi.org/10.1093/neuonc/noac209.832.
Texto completoPuccetti, Matteo, Claudio Costantini, Maurizio Ricci y Stefano Giovagnoli. "Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics". Pharmaceutics 13, n.º 4 (5 de abril de 2021): 494. http://dx.doi.org/10.3390/pharmaceutics13040494.
Texto completoTorralba, Manuel, Rossella Farra, Marianna Maddaloni, Mario Grassi, Barbara Dapas y Gabriele Grassi. "Drugs Repurposing in High-Grade Serous Ovarian Cancer". Current Medicinal Chemistry 27, n.º 42 (16 de diciembre de 2020): 7222–33. http://dx.doi.org/10.2174/0929867327666200713190520.
Texto completoTilija Pun, Nirmala y Chul-Ho Jeong. "Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance". Pharmaceuticals 14, n.º 5 (16 de mayo de 2021): 470. http://dx.doi.org/10.3390/ph14050470.
Texto completoMeng, Xin y Ye Wang. "Drug Repurposing for Influenza Virus Polymerase Acidic (PA) Endonuclease Inhibitor". Molecules 26, n.º 23 (2 de diciembre de 2021): 7326. http://dx.doi.org/10.3390/molecules26237326.
Texto completoEzquerra-Aznárez, José Manuel, Pedro E. Almeida da Silva y José A. Aínsa. "Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs". Microorganisms 9, n.º 11 (11 de noviembre de 2021): 2335. http://dx.doi.org/10.3390/microorganisms9112335.
Texto completoWang, Fei y Gabriele Multhoff. "Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies". Biomolecules 11, n.º 4 (15 de abril de 2021): 582. http://dx.doi.org/10.3390/biom11040582.
Texto completoFiscon, Giulia, Federica Conte, Lorenzo Farina y Paola Paci. "SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19". PLOS Computational Biology 17, n.º 2 (5 de febrero de 2021): e1008686. http://dx.doi.org/10.1371/journal.pcbi.1008686.
Texto completoPfab, Christina, Luisa Schnobrich, Samir Eldnasoury, André Gessner y Nahed El-Najjar. "Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?" Cancers 13, n.º 13 (26 de junio de 2021): 3193. http://dx.doi.org/10.3390/cancers13133193.
Texto completoPacios, Olga, Lucia Blasco, Inès Bleriot, Laura Fernandez-Garcia, Mónica González Bardanca, Antón Ambroa, María López, German Bou y Maria Tomás. "Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases". Antibiotics 9, n.º 2 (6 de febrero de 2020): 65. http://dx.doi.org/10.3390/antibiotics9020065.
Texto completoSchloer, Sebastian, Jonas Goretzko y Ursula Rescher. "Repurposing Antifungals for Host-Directed Antiviral Therapy?" Pharmaceuticals 15, n.º 2 (10 de febrero de 2022): 212. http://dx.doi.org/10.3390/ph15020212.
Texto completoStenvang, Jan, Christine Hjorth Andreassen y Nils Brünner. "Screening of 129 FDA approved anti-cancer drugs in colorectal cancer cell lines resistant to oxaliplatin or irinotecan (SN38)." Journal of Clinical Oncology 35, n.º 4_suppl (1 de febrero de 2017): 642. http://dx.doi.org/10.1200/jco.2017.35.4_suppl.642.
Texto completoChittepu, Veera C. S. R., Poonam Kalhotra, Tzayhri Osorio-Gallardo, Tzayhri Gallardo-Velázquez y Guillermo Osorio-Revilla. "Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study". Pharmaceutics 11, n.º 5 (17 de mayo de 2019): 238. http://dx.doi.org/10.3390/pharmaceutics11050238.
Texto completoRieber, Manuel. "Cancer Pro-oxidant Therapy Through Copper Redox Cycling: Repurposing Disulfiram and Tetrathiomolybdate". Current Pharmaceutical Design 26, n.º 35 (16 de octubre de 2020): 4461–66. http://dx.doi.org/10.2174/1381612826666200628022113.
Texto completoGaikwad, Shreyas Ramchandra y Sanjay K. Srivastava. "Abstract 580: A novel drug suppresses pancreatic cancer growth through immunomodulation". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 580. http://dx.doi.org/10.1158/1538-7445.am2023-580.
Texto completoJang, Woo Dae, Sangeun Jeon, Seungtaek Kim y Sang Yup Lee. "Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay". Proceedings of the National Academy of Sciences 118, n.º 30 (7 de julio de 2021): e2024302118. http://dx.doi.org/10.1073/pnas.2024302118.
Texto completoAgostini, Francesco, Anna Masato, Luigi Bubacco y Marco Bisaglia. "Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges". International Journal of Molecular Sciences 23, n.º 1 (30 de diciembre de 2021): 398. http://dx.doi.org/10.3390/ijms23010398.
Texto completoChen, Shun-Tsung, Chien-Hung Huang, Victor C. Kok, Chi-Ying F. Huang, Jin-Shuei Ciou, Jeffrey J. P. Tsai, Nilubon Kurubanjerdjit y Ka-Lok Ng. "Drug repurposing and therapeutic anti-microRNA predictions for inhibition of oxidized low-density lipoprotein-induced vascular smooth muscle cell-associated diseases". Journal of Bioinformatics and Computational Biology 15, n.º 01 (febrero de 2017): 1650043. http://dx.doi.org/10.1142/s0219720016500438.
Texto completoRana, Ritika, Ruchika Sharma y Anoop Kumar. "Repurposing of Fluvastatin Against Candida albicans CYP450 Lanosterol 14 α-demethylase, a Target Enzyme for Antifungal Therapy: An In silico and In vitro Study". Current Molecular Medicine 19, n.º 7 (2 de agosto de 2019): 506–24. http://dx.doi.org/10.2174/1566524019666190520094644.
Texto completoAhmad, Shaban. "Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid". Bioinformation 18, n.º 3 (31 de marzo de 2022): 170–79. http://dx.doi.org/10.6026/97320630018170.
Texto completoGuarnaccia, Laura, Giovanni Marfia, Matteo Maria Masseroli, Stefania Elena Navone, Melissa Balsamo, Manuela Caroli, Silvia Valtorta et al. "Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma". Cancers 14, n.º 1 (27 de diciembre de 2021): 112. http://dx.doi.org/10.3390/cancers14010112.
Texto completoBanaś, Patryk, Kamila Abram, Justyna Adamus, Jakub Rafał Pierzchała, Katarzyna Bednarz, Natalia Sobańska, Aleksandra Paulina Banasiak, Rafał Teichman, Jakub Kasprowicz y Michał Hyjek. "Multipotential use of an old drug, as a new solution for anticancer therapy and multidrug-resistant urinary tract infections". Journal of Education, Health and Sport 13, n.º 3 (1 de febrero de 2023): 165–74. http://dx.doi.org/10.12775/jehs.2023.13.03.024.
Texto completoLee, Chiyun y Sanjib Bhakta. "The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review". Antibiotics 10, n.º 1 (19 de enero de 2021): 91. http://dx.doi.org/10.3390/antibiotics10010091.
Texto completoAugustin, Yolanda, Henry M. Staines y Sanjeev Krishna. "Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing". Pharmacology & Therapeutics 216 (diciembre de 2020): 107706. http://dx.doi.org/10.1016/j.pharmthera.2020.107706.
Texto completoBhadra, Kakali. "A Mini Review on Molecules Inducing Caspase-Independent Cell Death: A New Route to Cancer Therapy". Molecules 27, n.º 19 (28 de septiembre de 2022): 6401. http://dx.doi.org/10.3390/molecules27196401.
Texto completoCabrera-Andrade, Alejandro, Andrés López-Cortés, Gabriela Jaramillo-Koupermann, Humberto González-Díaz, Alejandro Pazos, Cristian R. Munteanu, Yunierkis Pérez-Castillo y Eduardo Tejera. "A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing". Pharmaceuticals 13, n.º 11 (22 de noviembre de 2020): 409. http://dx.doi.org/10.3390/ph13110409.
Texto completoRub, Abdur, Kamal Shaker, Mohammad Kashif, Mohd Arish, Abdul Aziz Bin Dukhyil, Bader Mohammed Alshehri, Mohammed A. Alaidarous, Saeed Banawas y Khwaja Amir. "Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis". Protein & Peptide Letters 26, n.º 5 (29 de mayo de 2019): 371–76. http://dx.doi.org/10.2174/0929866526666190301114012.
Texto completoWang, Chih-Hung, Yi-Hsien Hsieh, Zachary M. Powers y Cheng-Yen Kao. "Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era". International Journal of Molecular Sciences 21, n.º 3 (5 de febrero de 2020): 1061. http://dx.doi.org/10.3390/ijms21031061.
Texto completoRoy, L., M. Poirier y D. Fortin. "P11.39 Chloroquine as an anti-glioblastoma therapeutic: repurposing of an old drug". Neuro-Oncology 21, Supplement_3 (agosto de 2019): iii51—iii52. http://dx.doi.org/10.1093/neuonc/noz126.185.
Texto completoHendrix, Andrew S., Thomas J. Spoonmore, Aimee D. Wilde, Nicole E. Putnam, Neal D. Hammer, Daniel J. Snyder, Scott A. Guelcher, Eric P. Skaar y James E. Cassat. "Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis". Antimicrobial Agents and Chemotherapy 60, n.º 9 (20 de junio de 2016): 5322–30. http://dx.doi.org/10.1128/aac.00834-16.
Texto completoVogel, Jens-Uwe, Sophie Schmidt, Daniel Schmidt, Florian Rothweiler, Benjamin Koch, Patrick Baer, Holger Rabenau et al. "The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation". Cells 9, n.º 1 (20 de diciembre de 2019): 31. http://dx.doi.org/10.3390/cells9010031.
Texto completoMedhasi, Sadeep, Ariya Chindamporn y Navaporn Worasilchai. "A Review: Antimicrobial Therapy for Human Pythiosis". Antibiotics 11, n.º 4 (26 de marzo de 2022): 450. http://dx.doi.org/10.3390/antibiotics11040450.
Texto completoRegan-Fendt, Kelly, Ding Li, Ryan Reyes, Lianbo Yu, Nissar A. Wani, Peng Hu, Samson T. Jacob, Kalpana Ghoshal, Philip R. O. Payne y Tasneem Motiwala. "Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma". Cancers 12, n.º 10 (23 de septiembre de 2020): 2730. http://dx.doi.org/10.3390/cancers12102730.
Texto completoDuarte, Diana, Armando Cardoso y Nuno Vale. "Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs". International Journal of Molecular Sciences 22, n.º 14 (10 de julio de 2021): 7408. http://dx.doi.org/10.3390/ijms22147408.
Texto completoPawełczyk, Anna y Lucjusz Zaprutko. "Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives". Future Medicinal Chemistry 12, n.º 19 (octubre de 2020): 1743–57. http://dx.doi.org/10.4155/fmc-2020-0204.
Texto completoSuematsu, Makoto. "Can drug repurposing stop “chase and run” between aldehydes and reactive sulfur species in anti-cancer therapy?" Oncotarget 9, n.º 77 (2 de octubre de 2018): 34453–54. http://dx.doi.org/10.18632/oncotarget.26170.
Texto completoCampbell, Courtney M., Avirup Guha, Tamanna Haque, Tomas G. Neilan y Daniel Addison. "Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review". Journal of Clinical Medicine 9, n.º 9 (11 de septiembre de 2020): 2935. http://dx.doi.org/10.3390/jcm9092935.
Texto completoChakravarty, Kaushik, Victor G. Antontsev, Maksim Khotimchenko, Nilesh Gupta, Aditya Jagarapu, Yogesh Bundey, Hypatia Hou, Neha Maharao y Jyotika Varshney. "Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform". Molecules 26, n.º 7 (29 de marzo de 2021): 1912. http://dx.doi.org/10.3390/molecules26071912.
Texto completoBerckmans, Yani, Yannick Hoffert, Ann Vankerckhoven, Erwin Dreesen y An Coosemans. "Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates". Pharmaceutics 15, n.º 7 (22 de junio de 2023): 1792. http://dx.doi.org/10.3390/pharmaceutics15071792.
Texto completoVicidomini, Caterina, Valentina Roviello y Giovanni N. Roviello. "Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L.) and Clues to Its Anti-COVID-19 Utility". Molecules 26, n.º 7 (26 de marzo de 2021): 1880. http://dx.doi.org/10.3390/molecules26071880.
Texto completoNgidi, Nolwazi Thobeka Portia, Kgothatso Eugene Machaba y Ndumiso Nhlakanipho Mhlongo. "In Silico Drug Repurposing Approach: Investigation of Mycobacterium tuberculosis FadD32 Targeted by FDA-Approved Drugs". Molecules 27, n.º 3 (20 de enero de 2022): 668. http://dx.doi.org/10.3390/molecules27030668.
Texto completo